Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Life Sci ; 204: 71-77, 2018 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-29738778

RESUMO

AIMS: Mutant EGFR Non-small cell lung cancer has benefit from gefitinib, but it has limited effect for wild-type EGFR tumors. Shikonin, a natural naphthoquinone isolated from a traditional Chinese medicine, the plant Lithospermum erythrorhizon (zicao), not only can inhibit the tumor growth, but also overcome cancer drug resistance. Our aim is to investigate whether shikonin can enhance antitumor effect of gefitinib in EGFR wild-type lung cancer cells in vitro and in vivo. MATERIALS AND METHODS: CCK-8 was used to determine the proliferation of EGFR wild-type non-small cell lung cancer. Apoptosis and cell cycle were detected by flow cytometry. PKM2, STAT3, p-STAT3 and cyclinD1 were detected by Western blot. A549 tumor model was established to observe the antitumor effect of shikonin combination with gefitinib in vivo. KEY FINDINGS: The results showed that combination of shikonin with gefitinib exhibited synergistic antitumor effect in vitro and in vivo. Its potential molecular mechanisms may be associated with inhibition of PKM2/STAT3/cyclinD1. SIGNIFICANCE: These results provide a promising therapeutic approach for the treatment of wild-type EGFR non-small cell lung cancer.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Antineoplásicos/farmacologia , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Receptores ErbB/efeitos dos fármacos , Neoplasias Pulmonares/tratamento farmacológico , Naftoquinonas/farmacologia , Quinazolinas/farmacologia , Transdução de Sinais/efeitos dos fármacos , Células A549 , Animais , Proteínas de Transporte/efeitos dos fármacos , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Ciclina D1/efeitos dos fármacos , Sinergismo Farmacológico , Gefitinibe , Humanos , Imuno-Histoquímica , Proteínas de Membrana/efeitos dos fármacos , Camundongos , Camundongos Nus , Fator de Transcrição STAT3/efeitos dos fármacos , Sincalida/efeitos dos fármacos , Hormônios Tireóideos , Proteínas de Ligação a Hormônio da Tireoide
2.
ChemMedChem ; 9(9): 2111-9, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25044832

RESUMO

In this study we demonstrated that ribonuclease A (RNase A) can recognize the thermodynamic asymmetry of siRNA duplexes, similar to other proteins involved in siRNA function such as argonaute 2. RNase A preferentially invades the siRNA duplex through the less stable terminus, i.e., the 3' terminus of the sense strand. As evidence, only phosphorothioate (PS) modification at the sense strand overhang improved serum stability, whereas PS modification at the antisense strand overhang did not affect stability. Moreover, the improvement in stability caused by modification at the sense strand overhang was found to correlate with the terminal base pair composition of the siRNA. Gel electrophoresis and MALDI-TOF MS analysis indicated that modifications at the sense strand overhang improved the serum stability of siRNAs by inhibiting the directional invasion of RNase A. The blocking effect was not brought about by stabilization of the siRNA duplexes because there was no clear difference between the melting temperatures of siRNAs with PS modifications at each 3' overhang.


Assuntos
RNA Interferente Pequeno/sangue , Ribonuclease Pancreático/sangue , Sequência de Bases , Códon , Células HEK293 , Células HeLa , Humanos , Dados de Sequência Molecular , Sincalida/efeitos dos fármacos , Sincalida/genética , Termodinâmica
3.
Nutrition ; 20(6): 536-41, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15165616

RESUMO

OBJECTIVE: We evaluated the long-term effects of a fat-enriched diet (virgin olive oil) on calcium mobilization and amylase secretion induced by cholecystokinin-octapeptide (CCK-8) in rat pancreatic acinar cells. Olive oil is a major component of the Mediterranean diet, and its role in human health is actively being debated. METHODS: Weaning male Wistar rats (21 d old) were assigned to one of two experimental groups and fed for 8 wk with a commercial chow (control group) or an experimental diet (olive group) containing 100 g/kg of virgin olive oil as dietary fat. Intracellular free calcium [Ca(2+)](i) levels were determined by loading the pancreatic cells with the fluorescent ratio-metric calcium indicator Fura-2 on an inverted fluorescent microscope. For measurement of amylase secretion, cells were incubated with the appropriate secretagogue for 30 min, and amylase activities in the supernatant were determined by the Phadebas blue starch method. Analysis of variance was used to test differences between groups. RESULTS: Compared with the control group, the CCK-8-induced increase in [Ca(2+)](i) occurred in cells from rats in the olive group (P < 0.05). This stimulatory effect of dietary virgin olive oil was observed in calcium oscillations and large [Ca(2+)](i) transients induced by low (20 pM/L) and high (10 nM/L) concentrations of CCK-8, respectively. In addition to the effects of dietary virgin olive oil on calcium mobilization, it increased (P < 0.05) amylase secretion in response to CCK-8. Olive oil treatment did not significantly alter resting [Ca(2+)](i) or amylase release values compared with the control group. Similar results were obtained when pancreatic acinar cells were stimulated with a high concentration of acetylcholine (10 microM/L). CONCLUSION: The present results demonstrate that a diet supplemented with virgin olive oil can modify pancreatic cell function as assessed by [Ca(2+)](i) mobilization and amylase release evoked by secretagogues in rat pancreatic acinar cells. A role for fatty acids in calcium signaling is suggested.


Assuntos
Amilases/metabolismo , Sinalização do Cálcio/efeitos dos fármacos , Gorduras Insaturadas na Dieta/farmacologia , Pâncreas/enzimologia , Óleos de Plantas/farmacologia , Sincalida/farmacologia , Amilases/efeitos dos fármacos , Análise de Variância , Animais , Cálcio/metabolismo , Sinalização do Cálcio/fisiologia , Suplementos Nutricionais , Fluorescência , Alimentos Formulados , Masculino , Azeite de Oliva , Pâncreas/efeitos dos fármacos , Pâncreas/metabolismo , Ratos , Ratos Wistar , Sincalida/efeitos dos fármacos
4.
Trends Pharmacol Sci ; 21(12): 475-83, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11121837

RESUMO

Generation and/or interruption of cell signalling by neuropeptides has been shown to be essentially, although not exclusively, mediated by one or several membrane-bound enzymes, giving rise to the concept of selective versus dual enzyme inhibitors. Because most of these enzymes are zinc metallopeptidases, novel inhibitors are now being designed based on the structure of these proteins. The physiological role of neuropeptides and their relationships with other peptide systems can be investigated by comparing results obtained using peptidase inhibitors and selective receptor antagonists with those obtained using mice in which genes encoding the various components of a peptide system have been deleted. The potential use of peptidase inhibitors, compared with exogenous agonists, as therapeutic agents (particularly as analgesics or antidepressants) and their use in the investigation of the neurobiology of drug abuse will be discussed with particular focus on enkephalins and cholecystokinin 8 (CCK-8).


Assuntos
Encefalinas/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Metaloendopeptidases/farmacologia , Inibidores de Proteases/farmacologia , Sincalida/efeitos dos fármacos , Animais , Ansiedade/tratamento farmacológico , Depressão/tratamento farmacológico , Dopamina/metabolismo , Encefalinas/metabolismo , Humanos , Metaloendopeptidases/química , Metaloendopeptidases/uso terapêutico , Camundongos , Neuropeptídeos/efeitos dos fármacos , Neuropeptídeos/metabolismo , Dor/tratamento farmacológico , Inibidores de Proteases/uso terapêutico , Receptores da Colecistocinina/antagonistas & inibidores , Receptores Opioides/efeitos dos fármacos , Recompensa , Sincalida/metabolismo , Transtornos Relacionados ao Uso de Substâncias/tratamento farmacológico
5.
Synapse ; 38(3): 238-42, 2000 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-11020226

RESUMO

Cholecystokinin octapeptide (CCK-8) coexists with dopamine (DA) in rat mesencephalic neurons that project to the nucleus accumbens. To obtain indices of corelease, microdialysis probes were placed in the posterior nucleus accumbens of anesthetized rats, which were then injected acutely (s.c.) with drugs that exert known effects on DA neuronal function. Microdialysis samples were assayed for DA and CCK-8 to determine the differential overflow of these cotransmitters in response to drug treatment. Haloperidol (0.5 mg/kg), d-amphetamine (1 mg/kg), and TCP (5 mg/kg) preferentially increased DA overflow, whereas morphine (5 mg/kg) elicited marked increases in the overflow of both DA and CCK-8. These results suggest that the release of accumbal DA and CCK-8 can be differentially regulated by drug treatment.


Assuntos
Dopamina/metabolismo , Núcleo Accumbens/metabolismo , Sincalida/metabolismo , Animais , Dextroanfetamina/farmacologia , Dopaminérgicos/farmacologia , Antagonistas de Dopamina/farmacologia , Haloperidol/farmacologia , Masculino , Morfina/farmacologia , Entorpecentes/farmacologia , Núcleo Accumbens/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Sincalida/efeitos dos fármacos
6.
Pancreas ; 10(2): 180-6, 1995 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-7536329

RESUMO

Peptide YY (PYY) inhibits exocrine pancreatic secretion in several species. Two receptors, Y1 and Y2, are known to mediate PYY actions. While PYY 1-36 binds equally to both receptor subtypes, a second endogenous form of PYY, PYY 3-36, selectively activates Y2 receptors. The importance of Y receptor subtypes for inhibition of exocrine pancreatic secretion by PYY is unknown. We studied the effects of PYY 1-36 on cholecystokinin octapeptide (CCK-8)-stimulated amylase secretion in an isolated perfused rat pancreas model. To characterize functionally the receptors involved we determined the effects of a Y1-selective agonist, [Pro34]PYY; a Y2 selective agonist, PYY 3-36; and neuropeptide Y (NPY) in this model. PYY 1-36 significantly inhibited stimulated amylase secretion in the denervated rat pancreas. [Pro34]PYY and NPY both inhibited exocrine pancreatic secretion as potently as PYY 1-36. Contrary to that, the Y2 selective agonist, PYY 3-36, was inactive. We conclude that PYY inhibits exocrine pancreatic secretion in this extrinsically denervated rat pancreas model by Y1 receptors.


Assuntos
Amilases/metabolismo , Pâncreas/metabolismo , Peptídeos/farmacologia , Receptores de Neuropeptídeo Y/efeitos dos fármacos , Sincalida/efeitos dos fármacos , Amilases/antagonistas & inibidores , Animais , Técnicas In Vitro , Masculino , Pâncreas/efeitos dos fármacos , Pâncreas/enzimologia , Peptídeo YY , Radioimunoensaio , Ratos , Ratos Wistar
7.
Physiol Behav ; 54(1): 95-100, 1993 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8327615

RESUMO

Microinjections of sulphated cholecystokinin octapeptide (sCCK-8) into the ventromedial nucleus of the hypothalamus inhibit lordosis behavior in receptive female rats. This effect of sCCK-8 seems to differentiate under the control of gonadal steroids shortly after birth. Neonatally castrated males and normal females show similar responses, while androgenized females are less sensitive to sCCK-8. The current study investigated estrogen's role on the differentiation of the response to sCCK-8. On the day of birth male rat pups were castrated, given sham surgeries, or implanted with the antiestrogen tamoxifen or the aromatase inhibitor androst-1, 4, 6-triene-3, 17-dione (ATD). Females were implanted with testosterone propionate or tamoxifen, or given sham surgeries. Implants were removed 10 days later. As adults, rats were tested for female sexual behavior after microinjections of sCCK-8 into the ventromedial nucleus of the hypothalamus. Neonatally castrated males, ATD-treated males, and control females showed profound inhibition of lordosis behavior after sCCK-8. These results suggest that elimination of estrogen postnatally prevents defeminization of the reproductive circuitry that responds to sCCK-8.


Assuntos
Androstatrienos/farmacologia , Estrogênios/fisiologia , Diferenciação Sexual/efeitos dos fármacos , Comportamento Sexual Animal/efeitos dos fármacos , Sincalida/efeitos dos fármacos , Tamoxifeno/farmacologia , Animais , Animais Recém-Nascidos , Estradiol/análogos & derivados , Estradiol/farmacologia , Feminino , Masculino , Gravidez , Ratos , Diferenciação Sexual/fisiologia , Comportamento Sexual Animal/fisiologia , Maturidade Sexual/efeitos dos fármacos , Maturidade Sexual/fisiologia , Núcleo Hipotalâmico Ventromedial/efeitos dos fármacos , Núcleo Hipotalâmico Ventromedial/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...